Skip to main content

Table 3 ACMG SF v2.0 genes classified per ACMG/AMP guidelines using InterVar software

From: Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls

Classification

Controls (982 exomes)

All cases (1173 exomes)

1 case/family (738 exomes)

 

Cancer genes

Non-cancer genes

Cancer genes

Non-cancer genes

Cancer genes

Non-cancer genes

Pathogenic

4 (17)

0

4 (13)

0

4 (7)

0

Likely pathogenic

0 (0)

8 (8)

0 (0)

11 (17)

0 (0)

10 (11)

Variant of unknown significance

141 (174)

403 (503)

179 (260)

440 (713)

140 (167)

336 (454)

Likely benign

248 (463)

398 (671)

242 (570)

417 (865)

202 (355)

332 (541)

Benign

12 (42)

30 (208)

12 (106)

28 (266)

11 (69)

26 (167)

No classification*

252 (3477)

832 (8181)

290 (4315)

814 (10393)

225 (2714)

668 (6535)

  1. Numbers represent unique variant count and number in parenthesis represents allele counts
  2. *Majority of the “no classification” variants were intronic, 5′/3′ untranslated regions, and 22 indels